Current Status of Bioprinting Using Polymer Hydrogels for the Production of Vascular Grafts

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68407700%3A21460%2F25%3A00380067" target="_blank" >RIV/68407700:21460/25:00380067 - isvavai.cz</a>

Výsledek na webu

<a href="https://doi.org/10.3390/gels11010004" target="_blank" >https://doi.org/10.3390/gels11010004</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.3390/gels11010004" target="_blank" >10.3390/gels11010004</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Current Status of Bioprinting Using Polymer Hydrogels for the Production of Vascular Grafts

Popis výsledku v původním jazyce

Cardiovascular disease is one of the leading causes of death and serious illness in Europe and worldwide. Conventional treatment—replacing the damaged blood vessel with an autologous graft—is not always affordable for the patient, so alternative approaches are being sought. One such approach is patient-specific tissue bioprinting, which allows for precise distribution of cells, material, and biochemical signals. With further developmental support, a functional replacement tissue or vessel can be created. This review provides an overview of the current state of bioprinting for vascular graft manufacturing and summarizes the hydrogels used as bioinks, the material of carriers, and the current methods of fabrication used, especially for vessels smaller than 6 mm, which are the most challenging for cardiovascular replacements. The fabrication methods are divided into several sections—self-supporting grafts based on simple 3D bioprinting and bioprinting of bioinks on scaffolds made of decellularized or nanofibrous material.

Název v anglickém jazyce

Current Status of Bioprinting Using Polymer Hydrogels for the Production of Vascular Grafts

Popis výsledku anglicky

Cardiovascular disease is one of the leading causes of death and serious illness in Europe and worldwide. Conventional treatment—replacing the damaged blood vessel with an autologous graft—is not always affordable for the patient, so alternative approaches are being sought. One such approach is patient-specific tissue bioprinting, which allows for precise distribution of cells, material, and biochemical signals. With further developmental support, a functional replacement tissue or vessel can be created. This review provides an overview of the current state of bioprinting for vascular graft manufacturing and summarizes the hydrogels used as bioinks, the material of carriers, and the current methods of fabrication used, especially for vessels smaller than 6 mm, which are the most challenging for cardiovascular replacements. The fabrication methods are divided into several sections—self-supporting grafts based on simple 3D bioprinting and bioprinting of bioinks on scaffolds made of decellularized or nanofibrous material.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30404 - Biomaterials (as related to medical implants, devices, sensors)

Projekt

<a href="/cs/project/NW24J-02-00061" target="_blank" >NW24J-02-00061: Cévní náhrady z decelularizovaných tkání kadaverózních dárců modifikované kmenovými buňkami a 3D biotiskem</a><br>

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2025

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Gels

ISSN

2310-2861

e-ISSN

—

Svazek periodika

11

Číslo periodika v rámci svazku

1

Stát vydavatele periodika

CH - Švýcarská konfederace

Počet stran výsledku

29

Strana od-do

—

Kód UT WoS článku

001403890500001

EID výsledku v databázi Scopus

2-s2.0-85216183107